Yunnan Baiyao Group stock

000538 · SZSE · CNY

Compare Yunnan Baiyao Group
¥56.40Change from previous close: +0.39%Absolute change: +¥0.22

Close · November 20, 2026

Price history

+0.64% over the period

1 year: from ¥56.04 (November 20, 2025) to ¥56.40 (November 20, 2026), +0.64%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026¥56.40
October 30, 2026¥53.71
September 30, 2026¥50.44
August 31, 2026¥50.39
July 31, 2026¥52.86
June 30, 2026¥47.37
May 29, 2026¥49.94
April 30, 2026¥53.05
March 31, 2026¥54.86
February 27, 2026¥56.05
January 30, 2026¥55.61
December 31, 2025¥56.76
November 28, 2025¥56.06
November 20, 2025¥56.04

At a glance

  • The company

    Sells pharmaceuticals, medicinal materials, health products and daily chemical products in China, including traditional Chinese medicine and medical devices

  • Latest results

    Quarter to September 30, 2026 · EPS ¥0.75 (estimate ¥0.75)

TickerLandia's take on Yunnan Baiyao Group

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low¥46.29
52-wk high¥58.20

−3.09% from the 52-week high

Analysts · 11 analysts

Average target¥66.38+17.69% vs. price

Buy 10 · Hold 1 · Sell 0 · Buy

TickerLandia Fingerprint: Yunnan Baiyao Group

Compared with similar companies: very low risk, very high dividend, and very high financial strength.

Financials and price compared with 39 companies in the drug manufacturers - specialty & generic industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Yunnan Baiyao Group is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), Yunnan Baiyao Group's P/E today is 19.5, below the median of its last 10 fiscal years (27.1; between 19.6 and 48.0 from 2016 to 2025). Yunnan Baiyao Group's P/E (trailing 12 months): 19.4, −32% against the median of a group of 11 similar companies (28.7).

P/E compared with its history

Compared with 11 similar companies

Yunnan Baiyao Group's metrics compared with similar companies
MetricYunnan Baiyao GroupPosition in the groupBand
P/E (trailing 12 months)19.4Middle
Forward P/E17.4Low
Operating margin11.2%Low
ROE13.0%Middle
Debt/equity0.01Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Yunnan Baiyao Group. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

¥10.37B

Latest quarter · Q3 2026

Net income

¥1.12B

Latest quarter · Q3 2026

Quarterly net margin

10.8%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
¥100.63B
P/E
19.4
EPS
¥2.91
Volume
11.99M
Daily trading
€77.42M
Dividend yield
2.81%
Last ex-dividend on April 30, 2026

How Yunnan Baiyao Group is changing

All results
  • Revenue grew 4.7% a year on average over the last 5 years

  • Free cash flow equal to 76% of net income

  • Revenue has grown for 9 fiscal years in a row

Returns

Yunnan Baiyao Group returns with dividends

¥1,000 invested in Yunnan Baiyao Group 5 years ago, on November 22, 2021, would be worth ¥1,077 today with dividends reinvested: +7.73% in total, +1.50% per year. On price alone it would be ¥879 (−12.06%).

PeriodYunnan Baiyao Group¥1,000 becomes
1 month+5.66%¥1,057
6 months+11.07%¥1,111
Year to date−0.63%¥994
1 year+5.80%¥1,058
3 years+29.10%¥1,291
5 years+7.73%¥1,077
10 years+56.92%¥1,569

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Yunnan Baiyao Group: technical analysis

Yunnan Baiyao Group shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 50.9% below its all-time closing high (¥114.86, February 10, 2021).

Trend
No clear trend
RSI (14 sessions)
69
Between 30 and 70
vs 200-session average
+7.15%

Active signals

  • Golden cross: the 50-session average has crossed above the 200-session average.

    since November 19, 2026

  • The last session opened more than 3% below the previous close.

Support and resistance

Price areas where Yunnan Baiyao Group has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance¥57.47+1.90%4 touches, last on April 3, 2026
  2. Last price¥56.40
  3. Support¥56.15−0.44%3 touches, last on November 3, 2026
  4. Support¥55.19−2.15%4 touches, last on March 4, 2026
  5. Support¥54.23−3.85%3 touches, last on October 19, 2026

Volatility and risk

Volatility (60 sessions, annualised)
15.1%
Largest fall in the last year
−18.10%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Yunnan Baiyao Group: seasonality

Average monthly price change over 33 years

+0.1%Jan+0.7%Feb+1.9%Mar+3.6%Apr+1.4%May+1.1%Jun+2.5%Jul+4.2%Aug+1.5%Sep+0.5%Oct+1.0%Nov+3.3%Dec

Over the last 33 years, the strongest month for Yunnan Baiyao Group has been August: +4.16% on average, positive in 19 years out of 33. The weakest has been January: +0.05% on average, positive in 12 years out of 33. November, the current month, has been positive in 16 years out of 32 (+1.00% on average).

Show chart data
MonthAverageMedianPositive years
January+0.05%−2.03%12 of 33
February+0.68%+0.71%17 of 33
March+1.89%+1.95%20 of 33
April+3.65%+0.83%20 of 33
May+1.36%+0.44%18 of 33
June+1.13%−1.67%14 of 33
July+2.52%+2.41%20 of 33
August+4.16%+1.52%19 of 33
September+1.46%+1.29%19 of 33
October+0.54%0.00%16 of 33
November+1.00%+0.20%16 of 32
December+3.33%+1.49%17 of 32

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Yunnan Baiyao Group and its competitors

Sales of pharmaceuticals form the core of the business, with the company also distributing medicinal materials, health products and daily chemical goods across China. Its traditional Chinese medicine range for pain management and anti-inflammation includes the Yunnan Baiyao aerosol, ointment and band-aid, while its portfolio extends to generic drugs and specialty medicines for cardiovascular health, respiratory ailments, gynecology and pediatrics. The group also makes medical devices and tea products and offers pharmaceutical supply chain services.

Headquarters
Kunming, China
Employees
9,286
Founded
1902
Chief executive
Ming Dong
Yunnan Baiyao Group and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Yunnan Baiyao Group000538$15.07B11.2%19.4+11.07%
PharmaEssentia6446$15.94B38.4%74.1+54.65%
Laurus LabsLAURUSLABS$14.13B24.1%97.8+68.58%
Shionogi4507$16.75B31.6%11.2+2.83%
Zydus LifesciencesZYDUSLIFE$12.92B17.2%28.7+15.29%
CiplaCIPLA$12.34B13.0%39.5+1.11%

Same industry or related industries, similar size. Compare Yunnan Baiyao Group with its competitors · Full profile